[Limited 5-fluorouracil-induced systemic scleroderma]

Ann Dermatol Venereol. 2009 Nov;136(11):816-8. doi: 10.1016/j.annder.2009.05.009. Epub 2009 Oct 9.
[Article in French]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Colectomy
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / surgery
  • Female
  • Fluorouracil / adverse effects*
  • Fluorouracil / therapeutic use*
  • Humans
  • Nifedipine / therapeutic use
  • Scleroderma, Systemic / chemically induced*
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / pathology
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Calcium Channel Blockers
  • Nifedipine
  • Fluorouracil